Crossref
Rethinking the Risk: Evaluation of The Malignant Potential of Non-16 and 18 HPV Types via Colposcopic Results
Van Medical Journal · 2024
DOI: 10.5505/vmj.2024.36035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Van Medical Journal, 2024. Verfasst von Serife Ozlem Genc und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Genc, S. O., Kurt, B., Koc, T., & Erdal, H. (2024). Rethinking the Risk: Evaluation of The Malignant Potential of Non-16 and 18 HPV Types via Colposcopic Results. Van Medical Journal. https://doi.org/10.5505/vmj.2024.36035
Vancouver
Genc SO, Kurt B, Koc T, Erdal H. Rethinking the Risk: Evaluation of The Malignant Potential of Non-16 and 18 HPV Types via Colposcopic Results. Van Medical Journal. 2024. doi:10.5505/vmj.2024.36035
BibTeX
@article{Genc2024,
author = {Genc, Serife Ozlem and Kurt, Begum and Koc, Tulay and Erdal, Huseyin},
title = {Rethinking the Risk: Evaluation of The Malignant Potential of Non-16 and 18 HPV Types via Colposcopic Results},
journal = {Van Medical Journal},
year = {2024},
doi = {10.5505/vmj.2024.36035}
}
EUVIMED